Drawing on literature on values in science and a case-study of UK cancer policy, this paper argues for a novel account of the demarcation project in terms of trustworthiness. The first part of the paper addresses the relationship between science, politics and demarcation. In 2010, the UK government decided to pay more for cancer drugs than for drugs for other diseases; in 2016, this Cancer Drugs Fund was reformed so as to lower the evidential standards for approving cancer drugs, rather than paying more for them. Are these two ways of treating cancer as “special” importantly different? This paper argues that, if we the argument from inductive risk seriously, they seem equivalent. This result provides further reason to doubt the notion of demarcating science from non-science. However, the second part of the paper complicates this story, arguing that considerations of epistemic trust might give us reasons to prefer epistemic communities centred around “broadly acceptable” standards, and which are “sociologically well-ordered”, regardless of inductive risk concerns. After developing these claims through the cancer case-study, the final section suggests how these concerns might motivate novel versions of the demarcation project.
...More
Chapter
Chu, Cecilia;
(2013)
Combating Nuisance: Sanitation, Regulation, and the Politics of Property in Colonial Hong Kong
(/isis/citation/CBB001214652/)
Book
Gaudillière, Jean-Paul;
Hess, Volker;
(2008)
Ways of Regulating: Therapeutic Agents between Plants, Shops and Consulting Rooms
(/isis/citation/CBB001221032/)
Book
Gaudillière, Jean-Paul;
Hess, Volker;
(2013)
Ways of Regulating Drugs in the 19th and 20th Centuries
(/isis/citation/CBB001252493/)
Article
Yildirim, Nuran;
Sert, Gürkan;
(2009/2010)
Eczacilik Mevzuatimizin Tarihsel Sürecinde Eczane Açma / Eczaci Olma Kosullari ve Hekim-Eczaci Iliskisi (1852--1953)
(/isis/citation/CBB001220729/)
Article
Gabriel, Joseph M.;
(2011)
Restricting the Sale of “Deadly Poisons”: Pharmacists, Drug Regulation, and Narratives of Suffering in the Gilded Age
(/isis/citation/CBB001220743/)
Article
Abraham, John;
Davis, Courtney;
(2006)
Testing Times: The Emergence of the Practolol Disaster and Its Challenge to British Drug Regulation in the Modern Period
(/isis/citation/CBB000770617/)
Article
Abraham, John;
Davis, Courtney;
(2009)
Drug Evaluation and the Permissive Principle: Continuities and Contradictions between Standards and Practices in Antidepressant Regulation
(/isis/citation/CBB000953573/)
Article
Larsen, Jakob Bjerg;
Mount, Jeanine K.;
Kruse, Poul R.;
Vrangbæk, Karsten;
(2004)
Dynamics of Pharmacy Regulation in Denmark, 1546--1932: A Study of Profession-State Relations
(/isis/citation/CBB000502231/)
Article
Hüntelmann, Axel C.;
(2008)
The Dynamics of Wertbestimmung
(/isis/citation/CBB000831748/)
Article
Sihn, Kyu-hwan;
(2013)
The Institutionalization of Pharmaceutical Administration after the Korean Liberation: Focusing on Regulating the Pharmaceutical Affairs Law (Yaksabeop) in 1953
(/isis/citation/CBB001214039/)
Chapter
Hess, Volker;
(2008)
Secrets, Bureaucracy and the Public Drug Regulation in Prussia of the Early 19th Century
(/isis/citation/CBB001221034/)
Article
Emmeline Ledgerwood;
(2022)
‘Armed with the necessary background of knowledge’: Embedding science scrutiny mechanisms in the UK Parliament
(/isis/citation/CBB795829526/)
Article
Shobita Parthasarathy;
(2022)
How to Be an Epistemic Trespasser
(/isis/citation/CBB968694595/)
Article
Larsen, Jakob Bjerg;
Mount, Jeanine K.;
Kruse, Poul R.;
Vrangbäk, Karsten;
(2004)
Dynamics of Pharmacy Regulation in Denmark, 1932--1994: A Study of Profession-State Relations
(/isis/citation/CBB000630318/)
Article
Kessel, Nils;
(2009)
Umstrittene Expertise. Der Beirat “Arzneimittel-sicherheit” in der bundesdeutschen Arzneimittel-regulierung, +1968--1976
(/isis/citation/CBB001220573/)
Chapter
Simon, Jonathan;
(2008)
French Serum Regulation in 1895: The Necessary Minimum or the Maximum Possible?
(/isis/citation/CBB001221038/)
Book
Carpenter, Daniel;
(2010)
Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA
(/isis/citation/CBB001020607/)
Book
Carl-Henry Geschwind;
(2017)
A Comparative History of Motor Fuels Taxation, 1909-2009: Why Gasoline Is Cheap and Petrol Is Dear
(/isis/citation/CBB741635451/)
Article
Lukas Engelmann;
Catherine M Montgomery;
Steve Sturdy;
Cristina Moreno Lozano;
(2023)
Domesticating models: On the contingency of Covid-19 modelling in UK media and policy
(/isis/citation/CBB186749249/)
Article
Koichi Mikami;
(2019)
Orphans in the Market: The History of Orphan Drug Policy
(/isis/citation/CBB788431131/)
Be the first to comment!